Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PGLYRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PGLYRP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
S100A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LELP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928009 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPRR2G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPRR2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPRR2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPRR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPRR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on